Mamas. (2021). Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation. The American Journal of Cardiology, 58 - 64. https://doi.org/10.1016/j.amjcard.2021.11.021